Financhill
Sell
44

EVAX Quote, Financials, Valuation and Earnings

Last price:
$2.91
Seasonality move :
-4.57%
Day range:
$2.88 - $3.04
52-week range:
$1.20 - $17.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.91x
P/B ratio:
1.77x
Volume:
65.5K
Avg. volume:
107.2K
1-year change:
-81.99%
Market cap:
$18.3M
Revenue:
$3.3M
EPS (TTM):
-$12.00

Analysts' Opinion

  • Consensus Rating
    Evaxion AS has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $13.25, Evaxion AS has an estimated upside of 358.48% from its current price of $2.89.
  • Price Target Downside
    According to analysts, the lowest downside price target is $6.00 representing 100% downside risk from its current price of $2.89.

Fair Value

  • According to the consensus of 1 analyst, Evaxion AS has 358.48% upside to fair value with a price target of $13.25 per share.

EVAX vs. S&P 500

  • Over the past 5 trading days, Evaxion AS has overperformed the S&P 500 by 3.58% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Evaxion AS does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Evaxion AS has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Evaxion AS reported revenues of $3M.

Earnings Growth

  • Evaxion AS has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Evaxion AS reported earnings per share of -$0.50.
Enterprise value:
412K
EV / Invested capital:
--
Price / LTM sales:
1.91x
EV / EBIT:
--
EV / Revenue:
0.12x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.02x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
-69.51%
Net Income Margin (TTM):
-347.86%
Return On Equity:
--
Return On Invested Capital:
-238.97%
Operating Margin:
-57.38%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-03-31 2024-03-31 2025-03-31 2024-03-31 2025-03-31
Income Statement
Revenue -- -- -- $51K --
Gross Profit -- -- -- -- --
Operating Income -$25.2M -$20.2M -$14.2M -$4.4M -$3.9M
EBITDA -$23.4M -$14.7M -$14.8M $1.2M -$1.4M
Diluted EPS -$48.50 -$27.00 -$12.00 $1.50 -$0.50
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Balance Sheet
Current Assets $32.5M $35.4M $10.2M $11.7M $17.8M
Total Assets $34.9M $41.1M $20.5M $22.7M $25.2M
Current Liabilities $6M $4.7M -- -- --
Total Liabilities $7.1M $14.7M $13.9M $22.7M $25.2M
Total Equity $27.8M $26.4M $6.6M -- --
Total Debt -- -- -- -- --
Trailing 12 Months Fiscal Quarters
Period Ending 2020-06-30 2021-06-30 2022-06-30 2021-06-30 2022-06-30
Cash Flow Statement
Cash Flow Operations -- -$18.7M -$23.8M -$7.5M -$5.2M
Cash From Investing -- -$1.1M -$744K -$495K -$77K
Cash From Financing -- $34.1M $32M -$35K -$300K
Free Cash Flow -- -$19.8M -$24.6M -$8M -$5.3M
EVAX
Sector
Market Cap
$18.3M
$34.2M
Price % of 52-Week High
16.28%
47.37%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.6%
1-Year Price Total Return
-81.99%
-35.99%
Beta (5-Year)
--
0.632
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $2.86
200-day SMA
Sell
Level $6.46
Bollinger Bands (100)
Buy
Level 1.33 - 2.97
Chaikin Money Flow
Sell
Level -58.8M
20-day SMA
Buy
Level $2.33
Relative Strength Index (RSI14)
Buy
Level 66.25
ADX Line
Buy
Level 39.83
Williams %R
Neutral
Level -20.037
50-day SMA
Buy
Level $1.82
MACD (12, 26)
Buy
Level 0.35
25-day Aroon Oscillator
Buy
Level 88
On Balance Volume
Neutral
Level 115.7M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-15.0971)
Sell
CA Score (Annual)
Level (-7.5054)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (9.7293)
--
Piotroski F Score (Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (0)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Evaxion AS is in the field of oncology. It used the AI-Immunology platform.

Stock Forecast FAQ

In the current month, EVAX has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The EVAX average analyst price target in the past 3 months is $13.25.

  • Where Will Evaxion AS Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Evaxion AS share price will rise to $13.25 per share over the next 12 months.

  • What Do Analysts Say About Evaxion AS?

    Analysts are divided on their view about Evaxion AS share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Evaxion AS is a Sell and believe this share price will drop from its current level to $6.00.

  • What Is Evaxion AS's Price Target?

    The price target for Evaxion AS over the next 1-year time period is forecast to be $13.25 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is EVAX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Evaxion AS is a Buy. 1 of 1 analysts rates the stock a Buy at this time.

  • How Can I Buy Shares Of EVAX?

    You can purchase shares of Evaxion AS via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Evaxion AS shares.

  • What Is The Evaxion AS Share Price Today?

    Evaxion AS was last trading at $2.91 per share. This represents the most recent stock quote for Evaxion AS. Yesterday, Evaxion AS closed at $2.89 per share.

  • How To Buy Evaxion AS Stock Online?

    In order to purchase Evaxion AS stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Ken Griffin Buy Sweetgreen Stock?
Why Did Ken Griffin Buy Sweetgreen Stock?

In Q1, Ken Griffin’s Citadel Advisors purchased nearly 1.3 million…

Where Will Planet Labs’ Stock Go Next?
Where Will Planet Labs’ Stock Go Next?

On 4 June 2025 Planet reported Q1 FY 2026 revenue of $66.3 million, up 10% year over…

Where Will VICI Properties Be in 5 Years?
Where Will VICI Properties Be in 5 Years?

VICI Properties (NYSE:VICI) is a real estate investment trust focused…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
73
OKLO alert for Jun 12

Oklo [OKLO] is down 1.63% over the past day.

Buy
87
SMR alert for Jun 12

NuScale Power [SMR] is up 0.63% over the past day.

Buy
53
PLAY alert for Jun 12

Dave & Buster's Entertainment [PLAY] is down 0% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock